Known targets — ChEMBL curated mechanism
ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | CA1 | P00915 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA3 | P07451 | 1/20 | 0.54 |
| ▸ | CA6 | P23280 | 1/20 | 0.54 |
| ▸ | CA5A | P35218 | 1/20 | 0.54 |
| ▸ | CA7 | P43166 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.54 |
| ▸ | NT5E | P21589 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methyl Alcohol SCHEMBL28016010 | 0.97 | GAA (0.56) | GAALMNAALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL11432043 | 0.97 | GAA (0.62) | GAALMNAALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL34 | 0.97 | GAA (0.62) | GAALMNAALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL1705904 | 0.97 | GAA (0.62) | GAALMNAALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL5068661 | 0.97 | GAA (0.62) | GAALMNAALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL29991938 | 0.97 | GAA (0.62) | GAALMNAALDH1A1SMN1; SMN2TDP1 | |
| P-Xylene SCHEMBL8660591 | 0.97 | GAA (0.62) | GAALMNAALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL31313 | 0.97 | GAA (0.62) | GAALMNAALDH1A1SMN1; SMN2TDP1 | |
| Hydrochloric Acid SCHEMBL6318584 | 0.95 | GAA (0.59) | GAALMNAALDH1A1SMN1; SMN2TDP1 | |
| SCHEMBL3038225 | 0.95 | GAA (0.59) | GAALMNAALDH1A1SMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12617889-B1 | Polymers for use as anion exchange membranes | ENVISION ENERGY USA LTD. (US) | 2026-05-05 | — | — | US | claimed |
| US-20260081133-A1 | ZINC ELECTRODE FOR ALKALINE NICKEL-ZINC BATTERY AND PREPARATION METHOD THEREFOR | DONGGUAN CHAO BA BATTERIES CO LTD SHENZHEN INNOVATION CENTER (CN) | 2026-03-19 | — | — | US | claimed |
| CN-119297214-A | Zinc electrode for alkaline nickel-zinc battery and preparation method of zinc electrode | 东莞超霸电池有限公司深圳创新中心 | 2025-01-10 | — | — | CN | claimed |
| CN-113087625-B | Method for synthesizing benzyl acetate by utilizing combined catalytic system | 潜江新亿宏有机化工有限公司 | 2022-04-01 | — | — | CN | claimed |
| CN-113135845-A | Method for extracting regenerated p-toluenesulfonic acid from doxycycline hydrochloride production wastewater | 昆山华苏生物科技有限公司 | 2021-07-20 | — | — | CN | claimed |
| CN-113087625-A | Method for synthesizing benzyl acetate by utilizing combined catalytic system | 潜江新亿宏有机化工有限公司 | 2021-07-09 | — | — | CN | claimed |
| CN-106905522-B | A kind of composite calcium-base catalyst and its application | 上海东大化学有限公司 | 2019-01-22 | — | — | CN | claimed |
| US-20180161365-A1 | Phosphate-Binding Magnesium Salts And Uses Thereof | CURRAX PHARMACEUTICALS LLC | 2018-06-14 | — | — | US | claimed |
| US-9889157-B2 | Phosphate-binding magnesium salts and uses thereof | CYPRESS PHARMACEUTICALS, INC. (US) | 2018-02-13 | — | — | US | claimed |
| US-20170202875-A1 | Phosphate-Binding Magnesium Salts And Uses Thereof | WILMINGTON SAVINGS FUND SOCIETY, FSB | 2017-07-20 | — | — | US | claimed |
| US-9339481-B2 | Phosphate-binding magnesium salts and uses thereof | CYPRESS PHARMACEUTICALS, INC. (US) | 2016-05-17 | — | — | US | claimed |
| CN-104637689-A | Electrolyte, method for manufacturing the same, composition for forming the same, and capacitor comprising the same | IND TECH RES INST | 2015-05-20 | — | — | CN | claimed |
| EP-2416786-A1 | PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF | Cypress Pharmaceutical, Inc. (US) | 2012-02-15 | — | — | EP | claimed |
| WO-2010117370-A1 | PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF | CYPRESS PHARMACEUTICALS, INC. (US) | 2010-10-14 | — | — | WO | claimed |
| US-20090269399-A1 | PHOSPHATE-BINDING MAGNESIUM SALTS AND USES THEREOF | CYPRESS PHARMACEUTICAL, INC. (US) | 2009-10-29 | — | — | US | claimed |
| US-5714641-A | REACTING PHENOLIC COMPOUND WITH HYDROGEN PEROXIDE IN PRESENCE OF STRONG ACID AND BENZOPHENONE CATALYST | RHONE-POULENC CHIMIE (FR) | 1998-02-03 | — | — | US | claimed |
| US-5434317-A | Hydroxylation of phenolic compounds | RHONE-POULENC CHIMIE (FR) | 1995-07-18 | — | — | US | claimed |
| EP-0480800-B1 | Process for hydroxylating of phenolic compounds | RHONE POULENC CHIMIE (FR) | 1994-08-03 | — | — | EP | claimed |
| EP-0408418-B1 | METHOD OF HYDROXYLATING PHENOLS AND PHENOL ETHERS | RHONE-POULENC CHIMIE (FR) | 1993-08-25 | — | — | EP | claimed |
| US-5097078-A | Using hydrogen peroxide | RHONE-POULENC CHIMIE (FR) | 1992-03-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260081133-A1 | ZINC ELECTRODE FOR ALKALINE NICKEL-ZINC BATTERY AND PREPARATION METHOD THEREFOR | SLC39A11, SLC30A7, SLC39A7 | GAA 752/4885LMNA 2911/4885ALDH1A1 3125/4885 |
| US-12617889-B1 | Polymers for use as anion exchange membranes | KCNN3, KCNJ1, KCNH3 | GAA 4622/4885LMNA 3277/4885ALDH1A1 4121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.